一个基于信息-动机-行为技能模型的干预,用于患者
1Jinshan Hospital, Fudan University, Shanghai 201508, China.
Epilepsy & behavior : E&B
|September 7, 2023
概括
使用信息-动机-行为技能 (IMB) 模型的健康教育显著改善了患者的自我管理,生活质量和药物坚持. 这种方法提供了一个以患者为中心的策略,以获得更好的治疗.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 卫生教育卫生教育教育
背景情况:
- 对于患者 (PWE) 来说,自我管理至关重要,以控制他们的病情并改善结果.
- 有效的自我管理策略可以提高治疗效率,减少发作的频率.
研究的目的:
- 以信息-动机-行为技能 (IMB) 模型为指导,评估健康教育对PWE的影响.
- 评估接受IMB基础教育的PWE在自我管理,生活质量和药物坚持方面的改进.
主要方法:
- 一个随机对照试验,涉及90个PWE在上海,中国 (2022年9月至2023年3月).
- 干预组接受了基于IMB模型的健康教育;对照组接受了例行护理.
- 测量结果包括自我管理能力,生活质量和干预后3个月和6个月的药物坚持.
主要成果:
- 干预组在3个月和6个月后显示出明显更高的自我管理得分 (P < 0.05).
- 6个月后,干预组的生活质量得分显著改善 (P < 0.05).
- 6个月后,干预组的药物坚持显着更高 (P <0.05).
结论:
- 基于IMB模型的健康教育是加强PWE自我管理的有效策略.
- 这种教育方法对生活质量和药物坚持有积极的影响.
- IMB模型为个性化,以患者为中心的病护理计划提供了一个框架.
相关概念视频
Arteries of the Lower Limbs
212
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
212
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339
Electroconvulsive Therapy
68
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
68
Antiepileptic Drugs: GABAergic Pathway Potentiators
452
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
452
Antiepileptic Drugs: Glutamate Antagonists
418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418
Antiepileptic Drugs: Potassium Channel Activators
210
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
210


